{"id":529,"date":"2019-03-25T09:00:00","date_gmt":"2019-03-25T09:00:00","guid":{"rendered":"https:\/\/isosolution-v2.staging.xiyx.ai\/news\/evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen\/"},"modified":"2019-03-25T09:00:00","modified_gmt":"2019-03-25T09:00:00","slug":"evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen","status":"publish","type":"iso_news","link":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/news\/evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen\/","title":{"rendered":"Evaluaci\u00f3n de 111In-DOTA-5D3, un Agente de Im\u00e1genes del SPECT Surrogate para Radioinmunoterapia de Membrana Prostate-Especifico Antigeno"},"content":{"rendered":"<p>5D3 es un nuevo anticuerpo monoclonal murino de alta afinidad espec\u00edfico para el ant\u00edgeno de membrana prost\u00e1tica espec\u00edfico (PSMA). PSMA es un objetivo para la imagen y terapia del c\u00e1ncer de pr\u00f3stata. 111Los anticuerpos etiquetados han sido usados como sustitutos para 177Terap\u00e9uticas etiquetadas con lu\/90Y. Nos caracterizamos 111In-DOTA-5D3 por im\u00e1genes SPECT\/CT, estudios de biodistribuci\u00f3n de tejidos y dosimetr\u00eda.<br \/>\n <a href=\"https:\/\/isosolutions.com\/evaluation-of-111in-dota-5d3\/\"><span aria-label=\"Continuar leyendo Evaluaci\u00f3n de 111In-DOTA-5D3, un agente de im\u00e1genes del SPECT Surrogate para la radioinmunoterapia del ant\u00edgeno de Membrana Prostate-Specific\">(m\u00e1s...)<\/span><\/a><\/p>\n<\/p><\/div>\n<p>Etiquetas: <a href=\"https:\/\/isosolutions.com\/news-tag\/immunoimaging\/\" rel=\"tag\">inmunoimaging<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/monoclonal-antibody\/\" rel=\"tag\">anticuerpo monoclonal<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/prostate-cancer\/\" rel=\"tag\">c\u00e1ncer de pr\u00f3stata<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/psma\/\" rel=\"tag\">PSMA<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/spect\/\" rel=\"tag\">SPECT<\/a> <a href=\"https:\/\/isosolutions.com\/news-tag\/spect-ct\/\" rel=\"tag\">SPECT\/CT<\/a><\/p>\n<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>5D3 is a new high-affinity murine monoclonal antibody specific for prostate-specific membrane antigen (PSMA). PSMA is a target for the imaging and therapy of prostate cancer. 111In-labeled antibodies\u2026<\/p>","protected":false},"featured_media":557,"template":"","iso_news_section":[43],"class_list":["post-529","iso_news","type-iso_news","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/wp-json\/wp\/v2\/iso_news\/529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/wp-json\/wp\/v2\/iso_news"}],"about":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/wp-json\/wp\/v2\/types\/iso_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/wp-json\/wp\/v2\/media\/557"}],"wp:attachment":[{"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/wp-json\/wp\/v2\/media?parent=529"}],"wp:term":[{"taxonomy":"iso_news_section","embeddable":true,"href":"https:\/\/isosolution-v2.staging.xiyx.ai\/es\/wp-json\/wp\/v2\/iso_news_section?post=529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}